E
ZYUS Life Sciences Corporation ZLSCF
$0.60 -$0.06-9.09%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Net Income -2.87M -3.52M -2.48M -18.00M -3.13M
Total Depreciation and Amortization 528.60K 531.30K 534.80K 599.00K 566.60K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 203.10K 146.90K 155.80K 14.44M -111.10K
Change in Net Operating Assets 1.04M 2.51M -171.30K 888.70K -3.74M
Cash from Operations -1.10M -323.70K -1.96M -2.07M -6.42M
Capital Expenditure -8.10K 0.00 -25.20K -141.10K -26.10K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- 0.00 0.00
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -8.10K 0.00 -25.20K -141.10K -26.10K
Total Debt Issued 300.00K 400.00K -- 0.00 0.00
Total Debt Repaid -2.60M -86.00K -341.00K -334.00K -551.00K
Issuance of Common Stock 3.31M -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 744.90K 229.50K -252.90K -245.50K -410.80K
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -359.30K -94.30K -2.23M -2.46M -6.85M
Weiss Ratings